Mounjaro (Tirzepatide): How It Works, Its Effects and How Long It Lasts

In the era of precision medicine, tirzepatide — marketed as Mounjaro, and in the United States also as Zepbound for weight management — represents far more than a weight-management drug. This molecule is redefining how we approach metabolic health, moving from a straightforward antidiabetic therapy towards a tool for systemic regeneration and cellular longevity. The real change isn’t losing weight, but regaining a metabolism that is physiologically young and self-regulating.

A note before we begin. Tirzepatide is a prescription-only medicine. This article is informational and doesn’t constitute a promotion of the drug or medical advice: it can only be prescribed after a clinical assessment establishing that it’s appropriate for you.

Is Mounjaro just a weight-loss drug, or something more?

The introduction of tirzepatide has provoked contrasting reactions in the medical world. On one hand, remarkable clinical data showing efficacy superior to any other weight-management drug. On the other, an understandable caution within the scientific community, wary of an excessively pharmacological approach to metabolic health.

The most recent evidence reveals a far more complex and interesting picture. Tirzepatide’s action isn’t limited to glycaemic control or appetite reduction: this molecule acts at deep levels of cellular physiology, modulating systemic inflammation, optimising mitochondrial function and restoring metabolic efficiency at a fundamental level.

The regenerative medicine paradigm Within a regenerative approach, tirzepatide becomes a physiological tool for metabolic rebalancing. It isn’t about forcing the body towards an aesthetic outcome, but about restoring its innate capacity to self-regulate, improving communication between cells, hormones and metabolic control systems.

How does tirzepatide (Mounjaro) work in the body?

What makes tirzepatide unique is its dual mechanism of action. Unlike traditional GLP-1 agonists (such as semaglutide, marketed as Ozempic and Wegovy), tirzepatide acts simultaneously on two key incretin receptors.

GLP-1 receptor — GLP-1 (glucagon-like peptide-1) is an incretin hormone that:

• Stimulates glucose-dependent insulin secretion
• Reduces glucagon secretion
• Slows gastric emptying
• Increases the feeling of fullness
• Protects pancreatic beta cells

GIP receptor — GIP (glucose-dependent insulinotropic polypeptide) acts on:

• Enhancement of the insulin response
• Modulation of lipid metabolism
• Reduction of visceral fat accumulation
• Improvement of insulin sensitivity
• Emerging neuroprotective effects

This dual, synergistic action explains why tirzepatide shows superior results compared with drugs acting on GLP-1 alone. It isn’t a simple additive effect, but a genuine molecular synergy that amplifies overall metabolic efficacy.

What are Mounjaro’s benefits beyond glycaemic control?

For decades, metabolic medicine has interpreted health through purely quantitative parameters: blood glucose, glycated haemoglobin, BMI, waist circumference. Important as they are, these indicators represent only the surface of a far deeper phenomenon.

The real question isn’t “how much does the patient weigh?” or “what is their blood glucose?”, but rather: how efficiently do their cells produce energy? How inflamed is their system? How functional are their mitochondria?

The three pillars of metabolic efficiency

1. Optimal insulin sensitivity Tirzepatide restores cells’ capacity to respond correctly to insulin, reducing the insulin resistance underlying obesity, type 2 diabetes, metabolic syndrome and accelerated ageing. More insulin-sensitive cells mean better glucose use, less fat accumulation and greater energy efficiency.

2. Reduction of systemic inflammation Obesity and diabetes are characterised by chronic low-grade inflammation. Tirzepatide reduces inflammatory markers such as CRP, IL-6 and TNF-alpha, creating a cellular environment more favourable to regeneration and longevity. Chronic inflammation is in fact one of the main drivers of ageing (inflammaging).

3. Optimisation of mitochondrial function Mitochondria are the cells’ power stations. Their efficiency determines our vitality, capacity to recover and cellular resilience. Tirzepatide improves mitochondrial biogenesis (the creation of new mitochondria) and their functional efficiency, increasing ATP production and reducing oxidative stress.

What is the Renew Protocol with tirzepatide?

In my clinical practice I’ve developed the Renew Protocol (Regenerative Enhancement and Natural Wellness), a therapeutic pathway that integrates tirzepatide within a complete, personalised regenerative medicine strategy.

The aim isn’t simply to make patients lose weight — an outcome achievable in many ways, often at the expense of health. The real goal is more ambitious: staying healthy over time, reducing systemic inflammation, optimising cellular function and preventing weight regain by restoring a physiologically self-regulating metabolism.

The three phases of the protocol

Phase 1 — Metabolic reset with tirzepatide The first phase uses tirzepatide to rapidly optimise the insulin response, reduce visceral fat (the most dangerous for health) and lower systemic inflammation. Throughout, we monitor body composition rather than weight alone: the goal is to lose fat mass while preserving muscle mass, essential for basal metabolism.

Phase 2 — Infusion support, when test results justify it Infusion therapies enter the pathway only if a laboratory finding warrants them, following the same principle I apply to every infusion: measure first, supplement second.

• Correcting documented deficiencies — iron, vitamin B12, vitamin D. This is the most solid indication, and during significant weight loss deficiencies are common: they should be looked for through testing, not assumed.
• NAD+ and glutathione — the biochemical rationale is real: NAD+ is a central coenzyme in mitochondrial energy metabolism, and glutathione is the principal endogenous antioxidant. It must be said honestly, however, that human clinical data for intravenous administration is still preliminary: I assess these case by case, discussing their limits openly, never as a promise.
• What an infusion doesn’t do — it doesn’t “detoxify”: the liver and kidneys perform that function extremely efficiently, and the detox drip is a commercial simplification rather than a physiological mechanism. Without a documented deficiency, excess water-soluble vitamins are simply eliminated in the urine.

I explore this further in the dedicated page on infusion therapy.

Phase 3 — Functional nutrition and targeted supplementation Long-term success depends on adopting a sustainable, personalised way of eating. Not temporary restrictive diets, but a functional nutritional approach that accounts for individual biotype, intolerances, gut microbiome and specific metabolic needs.

What results does the Renew Protocol achieve?

Patients following the Renew Protocol with tirzepatide experience improvements that go well beyond weight loss alone.

It should be said first that results vary from person to person and no outcome is guaranteed: the figures below reflect what clinical studies and practical experience show, not what can be promised.

Metabolic improvements:

• Reduction in body weight that, in clinical studies of tirzepatide, averages 15-20% over 6-9 months
• Normalisation of blood glucose and HbA1c
• Significant reduction in visceral fat
• Improved lipid profile (cholesterol, triglycerides)
• Reduction in blood pressure

Quality of life:

• Significant increase in energy and vitality
• Improved sleep quality
• Reduction in joint pain and inflammation
• Greater mental clarity and concentration
• Improved mood

Aesthetic effects:

• Improved skin tone and texture
• Reduction in bloating and fluid retention
• Brighter, firmer skin
• Redefinition of body contours

Biological markers:

• Reduction in inflammatory markers (CRP, IL-6)
• Improved liver function
• Optimised hormonal profile
• Reduced oxidative stress

What is metabolic efficiency, and why does it matter?

From the perspective of regenerative and preventive medicine, metabolic efficiency is one of the most significant indicators of systemic health and longevity potential.

Metabolic flexibility: the ability to switch smoothly between glucose and fat as an energy source, according to need. Rigid metabolisms, locked predominantly onto glucose, tend to accumulate fat and develop insulin resistance.

Mitochondrial efficiency: mitochondria that produce energy (ATP) optimally, with minimal waste and low free-radical production. Mitochondrial dysfunction underlies obesity, diabetes, cardiovascular and neurodegenerative disease.

Low baseline inflammation: cells and tissues that aren’t chronically inflamed allow more efficient repair and regeneration.

Preserved hormonal sensitivity: cellular receptors that respond correctly to hormonal signals (insulin, leptin, thyroid hormones), ensuring fine regulation of energy metabolism.

Metabolically healthy cells not only optimise energy processes and reduce chronic inflammation, but also improve tissue repair. This translates into visible benefits for skin quality (firmer, brighter, more elastic), body composition and the capacity to recover after physical or psychological stress.

How are results maintained in the long term?

One of the things that distinguishes the Renew Protocol from conventional approaches to weight loss is its meticulous attention to the maintenance phase. The body tends to defend its weight “set point” through metabolic, hormonal and behavioural adaptations. The goal is to reprogramme that set point to a healthier level and keep it stable over time.

Integrated monitoring system:

Periodic body composition assessments — advanced multi-frequency bioimpedance is used to monitor not just weight, but the distribution of fat mass, lean mass, and total and segmental water.

Personalised biochemical analysis — complete metabolic panels every 3-6 months include: fasting and post-prandial glucose and insulin, HbA1c, advanced lipid profile, inflammatory markers (CRP, homocysteine), liver and kidney function, thyroid profile, vitamin D, B12, iron and ferritin.

Metabolic efficiency testing — metabolic flexibility is assessed through specific tests measuring the body’s capacity to use different energy substrates.

Lifestyle adaptation — the patient is guided towards sustainable habits: personalised physical activity (not exhausting, but regular and enjoyable), stress management, sleep hygiene and mindful eating techniques.

If you’re coming from abroad

A few practical points for international patients, because rules differ considerably between countries.

An Italian prescription is required. Tirzepatide is prescription-only in Italy. A prescription issued in another country isn’t valid here, and treatment can’t simply be “continued” on arrival: a clinical assessment is needed to establish whether it’s appropriate for you.

The assessment comes first, always. Before any prescription, medical history, current medication, blood tests and body composition are reviewed. This isn’t bureaucracy: it’s what determines whether the treatment is suitable and safe in your specific case, and there are situations in which the correct answer is that it isn’t.

Regulatory framework and indications differ by country. What is approved, and for which indication, varies between Italy, the UK and the United States — as do the brand names. If you’ve read about this drug abroad, the information may not apply here.

Follow-up requires continuity. This is a pathway with periodic monitoring, not a one-off prescription. If your stay in Italy is short, it’s worth discussing at the outset how the follow-up will be managed.

Can Mounjaro help you become metabolically younger?

Within a controlled, evidence-based medical pathway, tirzepatide isn’t simply a weight-loss drug. It’s a physiological modulator of metabolic efficiency, capable of reactivating the body’s self-regulation and regeneration processes at a deep cellular level.

The Renew Protocol I’ve developed demonstrates its potential as part of a metabolic longevity strategy, where the real promise isn’t “losing weight” but staying healthy and metabolically young over time.

I firmly believe the future of medicine lies not in treating disease once it appears, but in preventing it by optimising cellular and metabolic function. Tirzepatide, integrated into a complete regenerative approach, is a powerful tool for that goal.

It isn’t about depending on a drug for life, but about using it strategically to reset the metabolism, reduce systemic inflammation, optimise mitochondrial function and build the foundations for lasting, self-sustaining wellbeing. This is regenerative medicine in its deepest sense: regenerating not only tissue, but the body’s entire metabolic architecture.

If you’d like to explore how the Renew Protocol with tirzepatide could transform your metabolic health, I invite you to book a personalised consultation.